EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins

Weijia Kong, Ganlin Zhang, Yue Wang, Jiahui Zhang, Tongjing Ding, Dong Chen, Yuancan Pan, Runxi Yi, Xiaohui Yin, Xiaomin Wang iD

Technology in Cancer Research & Treatment · 2024-01 · 23

DOI: 10.1177/15330338241281285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 09.09.2024. Verfasst von Weijia Kong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Glucuronidase, Biomarkers, Tumor, CTLA-4 Antigen, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Heparanase (HPSE), an endoglycosidase that cleaves heparan sulfate, regulates various biological processes related to tumor progression. We explore the prognostic value of HPSE and its relationship with immunotherapy response in patients with breast cancer, to improve the effectiveness of immunotherapy and increase the survival outcomes.

Methods

In the study, we explored the prognostic value of HPSE through the The Cancer Genome Atlas (TCGA) database. By using the single-sample gene set enrichment analysis (ssGSEA) method, we measured the infiltration levels of 24 immune cell types in the tumor microenvironment. Cancer Therapeutics Response Portal (CTRP) and PRISM datasets provide the area under the dose-response curve (AUC) to measure drug sensitivity. Using nomograms, we predicted overall survival ability. In vivo studies, we investigated the relationship between HPSE and immune checkpoint proteins and pro-inflammatory cytokines by immunohistochemistry of Triple-Negative Breast Cancer tumors in mice.

Results

Our model demonstrated that the integrating of HPSE with the clinical stage effectively predicts patients’ survival time, highlighting high HPSE expression as a prognostic risk factor for breast cancer. Then the Receiver Operating Characteristic (ROC) curve [AUC of 1 year = 0.747, AUC of 3 years = 0.731] and Decision Curve Analysis (DCA) curve illustrated the satisfactory discriminative capacity of our model, emphasizing its valuable clinical applicability. Immune-related results showed that HPSE correlates strongly with immune infiltrating cells, immune-related genes, and the anti-cancer immunity cycle. In vivo studies have demonstrated that HPSE in breast cancer is associated with increased expression of immune checkpoint proteins CD274 and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and is positively correlated with the pro-inflammatory cytokine TNF-α. Meanwhile, we analyzed the 11 types of drugs that are sensitive to the HPSE gene.

Conclusion

Our results show that HPSE can serve as an effective biomarker to predict the prognosis of breast cancer patients and reflect the impact of immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucuronidaseBiomarkers, TumorCTLA-4 AntigenBreast NeoplasmsTumor MicroenvironmentB7-H1 AntigenGene Expression Regulation, NeoplasticHumansFemalePrognosisAnimalsMiceImmune Checkpoint ProteinsROC CurveNomogramsComputational BiologyGene Expression ProfilingDatabases, GeneticHeparanase

Stichwörter der Autor:innen

breast cancerheparanaseimmune checkpoint proteins

Substanzen

GlucuronidaseBiomarkers, TumorCTLA-4 AntigenB7-H1 AntigenImmune Checkpoint ProteinsHeparanaseCD274 protein, humanCTLA4 protein, human

Autor:innen und Institutionen

  • Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Graduate School, Beijing University of Chinese Medicine, Beijing, China.

ORCID-Profile: Xiaomin Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Kong, W., Zhang, G., Wang, Y., Zhang, J., Ding, T., Chen, D., Pan, Y., Yi, R., Yin, X., & Wang, X. (2024). Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins. Technology in Cancer Research & Treatment, 23. https://doi.org/10.1177/15330338241281285

Vancouver

Kong W, Zhang G, Wang Y, Zhang J, Ding T, Chen D, et al. Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins. Technology in Cancer Research & Treatment. 2024;23. doi:10.1177/15330338241281285

BibTeX
@article{Kong2024,
  author = {Kong, Weijia and Zhang, Ganlin and Wang, Yue and Zhang, Jiahui and Ding, Tongjing and Chen, Dong and Pan, Yuancan and Yi, Runxi and Yin, Xiaohui and Wang, Xiaomin},
  title = {Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins},
  journal = {Technology in Cancer Research & Treatment},
  year = {2024},
  volume = {23},
  doi = {10.1177/15330338241281285}
}
Kostenlos starten →